Bifogade filer
Prenumeration
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
THIS PRESS RELEASE MAY NOT BE PUBLISHED, RELEASED, OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR TO AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SOUTH AFRICA, SWITZERLAND, SINGAPORE, UNITED KINGDOM, THE UNITED STATES, OR ANY OTHER JURISDICTION WHERE SUCH ACTION IS SUBJECT TO LEGAL RESTRICTIONS. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO ACQUIRE SECURITIES IN MODUS THERAPEUTICS HOLDING AB. SEE ALSO THE SECTION "IMPORTANT INFORMATION" BELOW.
The Board of Directors of Modus Therapeutics Holding AB ("Modus" or the "Company") has, in connection with the rights issue with pre-emptive rights for existing shareholders announced on November 8, 2023 (the “Rights Issue"), prepared an EU Growth Prospectus (the “Prospectus") which today has been approved and registered by the Swedish Financial Supervisory Authority.
Publication of Prospectus
The Prospectus has been prepared in connection with the Rights Issue and has today, on November 14, 2023, been approved and registered with the Swedish Financial Supervisory Authority. The Prospectus, containing complete terms and instructions, as well as subscription forms, is available on the Company's website (www.modustx.com) and on the website of Erik Penser Bank (www.penser.se). The Prospectus will also be available on the website of the Swedish Financial Supervisory Authority (www.fi.se).
Summary of the Rights Issue
- Shareholders in Modus will receive one (1) subscription right per share held on the record date of November 15, 2023
- Four (4) subscription rights entitle the holder to subscribe for five (5) new shares
- The subscription price is SEK 2.00 per share
- Trading in subscription rights will take place during the period from November 17 – November 28, 2023
- The subscription period runs from November 17 – December 1, 2023
The Rights Issue is covered by subscription commitments of approximately 43.8 percent. Upon full subscription in the Rights Issue, the Company will receive approximately SEK 40.3 million. For further information about the Rights Issue, please refer to the published Prospectus.
Advisors
Erik Penser Bank AB is the financial advisor to Modus in connection with the Issues, and Advokatfirman Vinge KB is the legal advisor.